Find generic entry opportunities
Proactively manage your pharmacy inventory
Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Manage your formulary budget
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Methods for treating HCV|
|Abstract:||This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.|
|Inventor(s):||Ray; Adrian S. (Burlingame, CA), Link; John O. (San Francisco, CA), Oldach; David W. (Chapel Hill, NC), Delaney, IV; William E. (Foster City, CA), Mo; Hongmei (Palo Alto, CA), Yang; Cheng Yong (Foster City, CA)|
|Assignee:||Gilead Pharmasset LLC (Foster City, CA)|
1. A method of treating an HCV infection in a human, comprising administering to the human: 1) compound 10 having the structure: ##STR00075## or a pharmaceutically
acceptable salt thereof and 2) compound 6 having the structure: ##STR00076## or a pharmaceutically acceptable salt thereof, wherein the method does not include administering interferon.
2. The method of claim 1 wherein compound 10 and compound 6 are administered orally.
3. The method of claim 1 wherein ribavirin an interferon is not administered to the human.
4. The method of claim 1 further comprising administering ribavirin to the human.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.